New evidence of CV risk with testosterone therapy

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-014-8224-6
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [21] Serum testosterone and the risk of prostate cancer: Potential implications for testosterone therapy
    Parsons, JK
    Carter, HB
    Platz, EA
    Wright, EJ
    Landis, P
    Metter, EJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (09) : 2257 - 2260
  • [22] Testosterone Therapy and Cardiovascular Risk: A Cautionary Tale
    Miner, Martin
    Heidelbaugh, Joel J.
    Morgentaler, Abraham
    JOURNAL OF MENS HEALTH, 2014, 11 (01) : 1 - 3
  • [23] Conclusions about testosterone therapy and cardiovascular risk
    Anawalt, Bradley D.
    Yeap, Bu B.
    ASIAN JOURNAL OF ANDROLOGY, 2018, 20 (02) : 152 - 153
  • [24] Testosterone replacement therapy and the risk of prostate cancer
    Warburton, Daniel
    Hobaugh, Christopher
    Wang, Grace
    Lin, Haocheng
    Wang, Run
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (06) : 878 - 881
  • [25] Testosterone Therapy and Cardiovascular Risk: Advances and Controversies
    Morgentaler, Abraham
    Miner, Martin M.
    Caliber, Monica
    Guay, Andre T.
    Khera, Mohit
    Traish, Abdulmaged M.
    MAYO CLINIC PROCEEDINGS, 2015, 90 (02) : 224 - 251
  • [26] Testosterone Therapy and Risk of Cardiovascular Disease in Men
    Cappola, Anne R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (17): : 1805 - 1806
  • [28] TESTOSTERONE THERAPY RAISES RISK OF VENOUS THROMBOEMBOLISM
    Rosenberg, Karen
    AMERICAN JOURNAL OF NURSING, 2020, 120 (04) : 50 - 50
  • [29] Risk of urolithiasis increased with testosterone replacement therapy
    Stone L.
    Nature Reviews Urology, 2019, 16 (6) : 330 - 330
  • [30] Postmenopausal testosterone therapy and breast cancer risk
    Somboonporn, W
    Davis, SR
    MATURITAS, 2004, 49 (04) : 267 - 275